Related Experiment Video
Updated: Jul 19, 2026
07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Use of nomograms as predictive tools in bladder cancer
Ahmad Shabsigh1, Bernard H Bochner
1Division of Urology, Memorial Sloan Kettering Cancer Center, Kimmel Center for Prostate and Urologic Cancers, 353 E. 68th Street, New York, NY 10021, USA.
World Journal of Urology
|November 2, 2006
Summary
Predicting bladder cancer recurrence and progression is crucial for effective treatment. Nomograms offer improved accuracy over traditional staging systems for guiding patient care and survival outcomes.
Area of Science:
- Urology
- Oncology
- Medical Statistics
Background:
- Bladder cancer exhibits significant variability in recurrence and progression post-treatment.
- Accurate risk prediction is essential for tailoring treatments, from surveillance to radical surgery and chemotherapy.
Purpose of the Study:
- To review current outcome predictive models for bladder cancer.
- To highlight the utility of nomograms in predicting recurrence, progression, and survival.
Main Methods:
- Review of existing literature on bladder cancer prognostic tools.
- Focus on the application and efficacy of nomograms.
Main Results:
- Traditional risk grouping (e.g., TNM staging) has limitations.
- Nomograms provide more precise outcome assessments for bladder cancer patients.
Conclusions:
- Nomograms represent a significant advancement in bladder cancer prognostication.
- These tools are valuable for clinical decision-making in managing bladder cancer patients.
